PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 34 filers reported holding PHARMATHENE INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $10,603,000 | -54.2% | 3,262,422 | -59.1% | 2.23% | -54.8% |
| Q3 2016 | $23,145,000 | +18.9% | 7,981,035 | 0.0% | 4.94% | +5.3% |
| Q2 2016 | $19,474,000 | +29.1% | 7,981,035 | 0.0% | 4.69% | +30.6% |
| Q1 2016 | $15,084,000 | -0.5% | 7,981,035 | 0.0% | 3.59% | +3.2% |
| Q4 2015 | $15,164,000 | +42.9% | 7,981,035 | 0.0% | 3.48% | +35.9% |
| Q3 2015 | $10,615,000 | -26.1% | 7,981,035 | 0.0% | 2.56% | -10.4% |
| Q2 2015 | $14,366,000 | +10.4% | 7,981,035 | 0.0% | 2.86% | +9.4% |
| Q1 2015 | $13,009,000 | -9.9% | 7,981,035 | 0.0% | 2.61% | +10.8% |
| Q4 2014 | $14,446,000 | +1.7% | 7,981,035 | 0.0% | 2.36% | -15.8% |
| Q3 2014 | $14,206,000 | +92.1% | 7,981,035 | +52.2% | 2.80% | +115.4% |
| Q2 2014 | $7,395,000 | -23.0% | 5,244,835 | 0.0% | 1.30% | -28.2% |
| Q1 2014 | $9,598,000 | -1.6% | 5,244,835 | 0.0% | 1.81% | -2.2% |
| Q4 2013 | $9,755,000 | -11.4% | 5,244,835 | 0.0% | 1.85% | -20.7% |
| Q3 2013 | $11,014,000 | +47.7% | 5,244,835 | +11.8% | 2.34% | +33.4% |
| Q2 2013 | $7,458,000 | – | 4,690,724 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|